Mahvash Tavassoli

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Venues

Cell death & disease

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyang Li, Celia González-Maroto, Mahvash Tavassoli
Crosstalk between CAFs and tumour cells in head and neck cancer. Cell death discovery 10 (1) (2024)
Xinyang Li, Celia González-Maroto, Mahvash Tavassoli
Crosstalk between CAFs and tumour cells in head and neck cancer. Cell death discovery 10 (1) (2024)
Xinyang Li, Celia González-Maroto, Mahvash Tavassoli
Crosstalk between CAFs and tumour cells in head and neck cancer. Cell death discovery 10 (1) (2024)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Danupon Nantajit, Luana Presta, Thomas Sauter, Mahvash Tavassoli
EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma. Cell death & disease 13 (11) (2022)

Mahvash Tavassoli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mahvash Tavassoli